| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736342 | Autoimmunity Reviews | 2018 | 18 Pages |
Abstract
Anakinra used late in the disease course led to a rapid and sustained improvement in clinical and biological inflammation. Our retrospective analysis did show neither a striking nor a rapid decrease of coronary dilatations and we cannot determine if anakinra itself had an effect on coronary artery dimensions.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Isabelle Kone-Paut, Rolando Cimaz, Jethro Herberg, Oliver Bates, Aurelia Carbasse, Jean Pierre Saulnier, Maria Cristina Maggio, Jordi Anton, Maryam Piram,